Protalix BioTherapeutics, Inc. Q2 2026 Earnings Call Summary
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
Behind the Uber-Rapido merger talks; Honasa’s strong Q1 report
Happy Friday! Uber and Rapido explored combining their India ride-hailing operations in May, sources told us. This and more in today’s ETtech Morning Dispatch.
Crypto criminals are increasingly attacking people, not passwords
So-called ‘wrench attacks’ involving kidnapping, home invasions and physical threats have already netted criminals more than $30m this year, says Philip Adiamah from Chainalysis.
BusinessDay forecast sees inflation easing to 15.51% in July
BusinessDay’s inflation economists project that Nigeria’s headline inflation will ease to 15.51 percent in July, dropping from the 15.91 percent read more BusinessDay forecast sees inflation easing to…
Debt grows slower than GDP, CAG says; revenue lapses persist
Government debt servicing remains positive, with loan accumulation below GDP expansion. However, irregularities worth ₹603 crore were found in the export incentive scheme.
UltraTech Cement promoter Pilani Investment sells 0.85% stake for ₹2,896 crore
The transaction brings several institutional investors into the cement maker’s shareholder base, even as its promoter group retains majority ownership.
Feds probe 'mention markets' amid White House Kalshi controversy
Betting on what people say is becoming an increasingly popular category of prediction market sites. Now, federal officials have opened a probe examining whether those markets are a magnet for…